As of Aug 17
| -0.001 / -3.32%|
The 1 analysts offering 12-month price forecasts for Amarantus Bioscience Holdings Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +30,827.84% increase from the last price of 0.03.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.